Polymer-lipid nanoparticles (PLN) have been a focus in cancer chemotherapy research due to their potential for targeting tumour cells, overcoming drug resistance and reducing toxicity. This work explores the (1) impact of “lipid” component properties and formulation parameters on PLN physicochemical properties and in vitro cytotoxicity using statistical design-of-experiments, and (2) mechanisms of PLN cell entry and organelle distribution, and response to lysosomal environments. These analyses show effects of melting point and chemical structure of multiple fatty acids/esters, and long heat exposure on PLN properties. As a result, a robust PLN system was optimized as a doxorubicin (DOX) delivery system for human glioblastoma U87-MG-RED-FLuc...
Lipid nanoparticles (LNPs) are currently having an increasing impact on nanomedicines as delivery ag...
Lipid nanoparticles (LNPs) are currently having an increasing impact on nanomedicines as delivery ag...
Lipid nanoparticles (LNPs) are currently having an increasing impact on nanomedicines as delivery ag...
In order to increase the efficacy of the cancer drug paclitaxel (PTX), scientists must develop more ...
Solid lipid nanoparticles (SLNs) are a promising system for the delivery of lipophilic and hydrophil...
Solid lipid nanoparticles (SLNs) are a promising system for the delivery of lipophilic and hydrophil...
Solid lipid nanoparticles (SLNs) are a promising system for the delivery of lipophilic and hydrophil...
Solid lipid nanoparticles (SLN) present low toxicity, versatility to incorporate both lipophilic and...
Drug delivery systems have opened new avenues to improve the therapeutic effects of already-efficien...
In this study, pEGFP-LUC was used as a model plasmid and three distinct cationic lipids (dioleyloxy-...
Solid lipid nanoparticles (SLN) present low toxicity, versatility to incorporate both lipophilic and...
Solid lipid nanoparticles (SLNs) are a promising system for the delivery of lipophilic and hydrophil...
Doxorubicin (DOX) is an antineoplastic agent clinically employed for treating breast cancer patients...
The e±cacy and safety are two challenging factors before trusting the lipid-based Nanosystems (LBNs...
Lipid nanoparticles (LNPs) are currently having an increasing impact on nanomedicines as delivery ag...
Lipid nanoparticles (LNPs) are currently having an increasing impact on nanomedicines as delivery ag...
Lipid nanoparticles (LNPs) are currently having an increasing impact on nanomedicines as delivery ag...
Lipid nanoparticles (LNPs) are currently having an increasing impact on nanomedicines as delivery ag...
In order to increase the efficacy of the cancer drug paclitaxel (PTX), scientists must develop more ...
Solid lipid nanoparticles (SLNs) are a promising system for the delivery of lipophilic and hydrophil...
Solid lipid nanoparticles (SLNs) are a promising system for the delivery of lipophilic and hydrophil...
Solid lipid nanoparticles (SLNs) are a promising system for the delivery of lipophilic and hydrophil...
Solid lipid nanoparticles (SLN) present low toxicity, versatility to incorporate both lipophilic and...
Drug delivery systems have opened new avenues to improve the therapeutic effects of already-efficien...
In this study, pEGFP-LUC was used as a model plasmid and three distinct cationic lipids (dioleyloxy-...
Solid lipid nanoparticles (SLN) present low toxicity, versatility to incorporate both lipophilic and...
Solid lipid nanoparticles (SLNs) are a promising system for the delivery of lipophilic and hydrophil...
Doxorubicin (DOX) is an antineoplastic agent clinically employed for treating breast cancer patients...
The e±cacy and safety are two challenging factors before trusting the lipid-based Nanosystems (LBNs...
Lipid nanoparticles (LNPs) are currently having an increasing impact on nanomedicines as delivery ag...
Lipid nanoparticles (LNPs) are currently having an increasing impact on nanomedicines as delivery ag...
Lipid nanoparticles (LNPs) are currently having an increasing impact on nanomedicines as delivery ag...
Lipid nanoparticles (LNPs) are currently having an increasing impact on nanomedicines as delivery ag...